Studies of apoptosis using BM aspirate and biopsy from MDS patients
Serial no. . | FAB classification . | BM aspirate . | BM biopsy . | ||
---|---|---|---|---|---|
Apoptotic cells by EM, % . | Semiquantitative assessment* . | ||||
LDF . | HDF . | ISEL . | EM . | ||
1 | Donor | 1 | 2 | 3 | 0 |
2 | 4 | 7 | 0 | 0 | |
3 | 2 | 5 | NA | 1 | |
4 | 1 | 3 | 0 | NA | |
MDS | |||||
5 | RA | 6 | 22 | 1 | 4 |
6 | RA | 16 | 29 | 7 | 3 |
7 | RA | 3 | 18 | 3 | 1 |
8 | RA | 8 | 20 | 3 | 2 |
9 | RA | 12 | 26 | 2 | 4 |
10 | RA | 19 | 44 | 4 | 4 |
11 | RA | 9 | 28 | NE | 5 |
12 | RARS | 0 | 30 | 0 | 3 |
13 | RARS | 4 | 26 | 6 | 5 |
14 | RARS | 14 | 32 | 4 | 4 |
Serial no. . | FAB classification . | BM aspirate . | BM biopsy . | ||
---|---|---|---|---|---|
Apoptotic cells by EM, % . | Semiquantitative assessment* . | ||||
LDF . | HDF . | ISEL . | EM . | ||
1 | Donor | 1 | 2 | 3 | 0 |
2 | 4 | 7 | 0 | 0 | |
3 | 2 | 5 | NA | 1 | |
4 | 1 | 3 | 0 | NA | |
MDS | |||||
5 | RA | 6 | 22 | 1 | 4 |
6 | RA | 16 | 29 | 7 | 3 |
7 | RA | 3 | 18 | 3 | 1 |
8 | RA | 8 | 20 | 3 | 2 |
9 | RA | 12 | 26 | 2 | 4 |
10 | RA | 19 | 44 | 4 | 4 |
11 | RA | 9 | 28 | NE | 5 |
12 | RARS | 0 | 30 | 0 | 3 |
13 | RARS | 4 | 26 | 6 | 5 |
14 | RARS | 14 | 32 | 4 | 4 |
NA indicates not available; NE, not evaluable.
Scale, 1 to 8.